This CTD dossier owner and manufacturer, established over three decades ago in South Asia, has become a prominent player in the global pharmaceutical market. Their focus lies in manufacturing and exporting a wide array of pharmaceutical products, including prescription and over-the-counter medications, to regulated and non-regulated markets worldwide. They have a strong presence in regions like Latin America, the Middle East, CIS, and Asia, with a subsidiary established in the Caucasus. Their commitment to quality is evident through adherence to WHO GMP standards, along with EU and USFDA guidelines. They specialize in manufacturing solid dosage forms and have a diverse range of therapeutic areas, although specific details were not provided.

This CTD dossier owner and manufacturer specializes in the manufacturing, import, and export of a diverse range of healthcare products. Their portfolio includes over 300 registered pharmaceutical products spanning various therapeutic areas, primarily delivered through tablets, capsules, dry suspensions, injectables, and sachets. The company operates a state-of-the-art manufacturing facility equipped with modern technology to ensure high-quality production according to international standards. They are committed to research and development, aiming to provide innovative healthcare solutions globally. Their focus extends beyond manufacturing, encompassing market research and the promotion of pharmaceutical products across regions like the EU and North America.